A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical Practice
Clinical trial NCT07602530 · RECRUITING
Trial details
- NCT number
- NCT07602530
- Sponsor
- Astellas Pharma Europe Ltd.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-10-23
- Primary completion
- 2027-02-28
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.